Arcturus Therapeutics Ltd.(ARCT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ARCT Arcturus Therapeutics Ltd.

Trading 04-06 15:51:20 EDT

8.24

+0.21

+2.61%

High8.54	Low8.06	Vol322.79K
Open8.07	D1 Closing8.03	Amplitude5.98%
Mkt Cap234.10M	Tradable Cap216.49M	Total Shares28.41M
T/O2.69M	T/O Rate1.23%	Tradable Shares26.28M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ARCT","market":"US","secType":"STK","nameCN":"Arcturus Therapeutics Ltd.","latestPrice":8.2394,"timestamp":1775505077522,"preClose":8.03,"halted":0,"volume":322789,"delay":0,"changeRate":0.026077210460772167,"floatShares":26275300,"shares":28412537,"eps":-2.402066,"marketStatus":"Trading","change":0.2094,"latestTime":"04-06 15:51:20 EDT","open":8.07,"high":8.54,"low":8.06,"amount":2687276.204231,"amplitude":0.059776,"askPrice":8.24,"askSize":275,"bidPrice":8.23,"bidSize":67,"shortable":3,"etf":0,"ttmEps":-2.402066,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1775505600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":8.03,"preHourTrading":{"tag":"盘前","latestPrice":8.07,"preClose":8.03,"latestTime":"09:28 EDT","volume":887,"amount":7132.680111000001,"timestamp":1775482081087,"change":0.04,"changeRate":0.004981,"amplitude":0.029888},"postHourTrading":{"tag":"盘后","latestPrice":7.88,"preClose":8.03,"latestTime":"19:44 EDT","volume":3610,"amount":28931.1046,"timestamp":1775173492336,"change":-0.15,"changeRate":-0.01868,"amplitude":0.024907},"volumeRatio":0.465737,"impliedVol":1.0932,"impliedVolPercentile":0.56},"requestUrl":"/m/hq/s/ARCT/tweets","defaultTab":"tweets","newsList":[{"id":"2622224892","title":"Roth MKM Keeps Their Buy Rating on Arcturus Therapeutics (ARCT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2622224892","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622224892?lang=en_us&edition=fundamental","pubTime":"2026-03-27 06:55","pubTimestamp":1774565728,"startTime":"0","endTime":"0","summary":"Roth MKM analyst Adam Walsh reiterated a Buy rating on Arcturus Therapeutics today and set a price target of $20.00. Walsh covers the Healthcare se...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/roth-mkm-keeps-their-buy-rating-on-arcturus-therapeutics-arct-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/roth-mkm-keeps-their-buy-rating-on-arcturus-therapeutics-arct-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620533842","title":"Arcturus Therapeutics Holdings Inc : B. Riley Initiates Coverage With Buy Rating; Price Target $22","url":"https://stock-news.laohu8.com/highlight/detail?id=2620533842","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620533842?lang=en_us&edition=fundamental","pubTime":"2026-03-18 20:03","pubTimestamp":1773835392,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nFWN40613X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ARCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620623981","title":"Arcturus Therapeutics initiated with a Buy at B. Riley","url":"https://stock-news.laohu8.com/highlight/detail?id=2620623981","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620623981?lang=en_us&edition=fundamental","pubTime":"2026-03-18 17:05","pubTimestamp":1773824717,"startTime":"0","endTime":"0","summary":"B. Riley initiated coverage of Arcturus Therapeutics (ARCT) with a Buy rating and $22 price target The firm says the company “stands out” given its...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/arcturus-therapeutics-initiated-with-a-buy-at-b-riley-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/arcturus-therapeutics-initiated-with-a-buy-at-b-riley-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","ARCT","BK4139","BK4007","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620238304","title":"U.S. RESEARCH ROUNDUP-Factset, Lensar, Starbucks","url":"https://stock-news.laohu8.com/highlight/detail?id=2620238304","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620238304?lang=en_us&edition=fundamental","pubTime":"2026-03-18 15:36","pubTimestamp":1773819417,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Factset, Lensar, StarbucksMarch 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies on Wednesday, including Fa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nL8N4060HY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CE","ETR","CLYM","COHX","GEMI","GHM","ECL","LU1992135472.HKD","STZ","CTMX","IE00BMG7P926.USD","DOCU","EQIX","BTGO","FICO","ANDG","FDS","LU1923621640.USD","COHR","HQY","CF","ALDX","APGE","ASO","GLGG","CADL","XYZ","BL","CCL","APD","LU2360107671.USD","GLXU","ANRO","DUOL","GLXY","DOW","GEMG","DC","EVMN","XYZG","BKKT","ARCT","DTE","AJG","CLH","BTSG","DLR","CRC","XYZY","CALM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617528052","title":"Arcturus Therapeutics to Join Leerink Partners 2026 Global Healthcare Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2617528052","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617528052?lang=en_us&edition=fundamental","pubTime":"2026-03-05 22:01","pubTimestamp":1772719319,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcturus Therapeutics Holdings Inc. published the original content used to generate this news brief via Business Wire  on March 05, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nNDL15HMXH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARCT","MNSH","BK4207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617518753","title":"Regulatory Shifts Cloud Arcturus Therapeutics’ Outlook as FDA Delays KOSTAIVE BLA and Demands New COVID-19 Efficacy Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2617518753","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617518753?lang=en_us&edition=fundamental","pubTime":"2026-03-05 14:00","pubTimestamp":1772690441,"startTime":"0","endTime":"0","summary":"Arcturus Therapeutics (ARCT) has disclosed a new risk, in the Regulation category. Arcturus Therapeutics faces heightened uncertainty as evolving U...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/regulatory-shifts-cloud-arcturus-therapeutics-outlook-as-fda-delays-kostaive-bla-and-demands-new-covid-19-efficacy-data?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/regulatory-shifts-cloud-arcturus-therapeutics-outlook-as-fda-delays-kostaive-bla-and-demands-new-covid-19-efficacy-data?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4551","BK4139","BK4588","BK4548","BK4539","BNTX","LENZ","BK4535","BK4585","BK4007","BK4568","ARCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616120558","title":"Arcturus Therapeutics (ARCT) Gets a Hold from H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2616120558","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616120558?lang=en_us&edition=fundamental","pubTime":"2026-03-04 20:56","pubTimestamp":1772628993,"startTime":"0","endTime":"0","summary":"In a report released today, Andrew Fein from H.C. Wainwright maintained a Hold rating on Arcturus Therapeutics, with a price target of $9.00. Fein ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/arcturus-therapeutics-arct-gets-a-hold-from-h-c-wainwright-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/arcturus-therapeutics-arct-gets-a-hold-from-h-c-wainwright-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARCT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616534359","title":"Analysts Offer Insights on Healthcare Companies: Rigel (RIGL), Arcturus Therapeutics (ARCT) and Intellia Therapeutics (NTLA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2616534359","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616534359?lang=en_us&edition=fundamental","pubTime":"2026-03-04 19:10","pubTimestamp":1772622614,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Rigel (RIGL – Research Report), Arcturus Therapeutic...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-rigel-rigl-arcturus-therapeutics-arct-and-intellia-therapeutics-ntla-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-rigel-rigl-arcturus-therapeutics-arct-and-intellia-therapeutics-ntla-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4585","LU0128526141.USD","BK4139","BK4535","BK4588","BK4581","ARCT","LU1861559042.SGD","BK4556","BK4137","HCSG","XLV","LABU","NTLA","LU1861558580.USD","LU0029874061.USD","RIGL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616323533","title":"U.S. RESEARCH ROUNDUP-CrowdStrike, Oracle, Vulcan Materials","url":"https://stock-news.laohu8.com/highlight/detail?id=2616323533","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616323533?lang=en_us&edition=fundamental","pubTime":"2026-03-04 17:14","pubTimestamp":1772615645,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-CrowdStrike, Oracle, Vulcan MaterialsMarch 4 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Crowd","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nL4N3ZS0PY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LZ","NTLA","LITE","GDRX","CMI","HON","ITW","NCLH","NVR","ADBE","CRWD","NHI","MRAL","ADBG","KBDC","IMRA","ACAD","DUK","ORCL","BBY","ARCT","FANG","AZO","NCDL","ORCX","ORCU","LITX","CRWL","ORCS","CHYM","ANAB","BOX","CAT","CRC","MO","KTB","LTC","MAAY","TGT","TREE","GTLB","SWIM","MARO","MARA","OFRM","BMRN","FIGS","MTH","KBH","DHI"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2616372736","title":"Arcturus Therapeutics Holdings Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2616372736","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616372736?lang=en_us&edition=fundamental","pubTime":"2026-03-04 06:01","pubTimestamp":1772575288,"startTime":"0","endTime":"0","summary":"Arcturus Therapeutics Holdings Inc reports results for the quarter ended December 31 - Earnings SummaryArcturus Therapeutics Holdings Inc ARCT.OQ reported a quarterly adjusted loss of $1.03 per share ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nL8N3ZR38A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARCT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616737103","title":"Arcturus Therapeutics Q4 net loss narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2616737103","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616737103?lang=en_us&edition=fundamental","pubTime":"2026-03-04 05:09","pubTimestamp":1772572187,"startTime":"0","endTime":"0","summary":"Arcturus Therapeutics Q4 net loss narrowsOverviewmRNA medicines firm's Q4 revenue fell due to reduced CSL collaboration activityOperating expenses for Q4 decreased, driven by lower manufacturing and c","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nL1N3ZR192:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARCT","BK7508","BK7067","CSL.AU","BK7511","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616719813","title":"BRIEF-Arcturus Therapeutics Q4 Net Income USD -29.079 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2616719813","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616719813?lang=en_us&edition=fundamental","pubTime":"2026-03-04 05:01","pubTimestamp":1772571706,"startTime":"0","endTime":"0","summary":"BRIEF-Arcturus Therapeutics Q4 Net Income USD -29.079 Million\n\n\nMar 03 (Reuters) - Arcturus Therapeutics Q4 collaboration revenue USD 3.081 million.\n\nQ4 basic EPS USD -1.03\nQ4 operating expenses USD 38.503 million\nQ4 operating income USD -31.307 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nPLX3C80C1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARCT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616371607","title":"Arcturus Q4 FY2025 total revenue drops 68.4% to USD 7.2 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2616371607","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616371607?lang=en_us&edition=fundamental","pubTime":"2026-03-04 05:01","pubTimestamp":1772571692,"startTime":"0","endTime":"0","summary":"Arcturus Q4 FY2025 total revenue drops 68.4% to USD 7.2 million               Arcturus Therapeutics reported Q4 FY2025 total revenue of USD 7.2 million (down 68.4%), including collaboration revenue of","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDL5Wnbnt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616937161","title":"Arcturus Therapeutics Q4 Collaboration Revenue USD 3.081 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2616937161","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616937161?lang=en_us&edition=fundamental","pubTime":"2026-03-04 05:01","pubTimestamp":1772571661,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nPLX3C80C1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ARCT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616645371","title":"Arcturus Therapeutics Q4 Operating Expenses USD 38.503 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2616645371","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616645371?lang=en_us&edition=fundamental","pubTime":"2026-03-04 05:01","pubTimestamp":1772571661,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nPLX3C80C1:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ARCT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616083333","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2616083333","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616083333?lang=en_us&edition=fundamental","pubTime":"2026-03-02 19:00","pubTimestamp":1772449200,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Crawford & Co                                  4Q       .23   4:15 PM. ·Credo Tech Hldg                                 3Q       .91   4:05 PM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CORZ","BRCB","DDD","ALLO","BEEP","AAON","FSTR","AZO","ASTH","DAVE","EOLS","LIF","AMLX","ADT","ASAN","AFCG","AMRC","CERS","CRD.B","CXDO","GAIA","ANF","CVEO","BLTE","EVGO","AEO","STNE","BGS","ACR","CRD.A","BOX","NPCE","ACHR","HCAT","BBY","BCYC","ACEL","CGEN","ALG","ARCT","GTLB","CRCT","ATRA","CYRX","CRC","ANTA"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2614234867","title":"Arcturus Therapeutics Holdings Inc  expected to post a loss of 71 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2614234867","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614234867?lang=en_us&edition=fundamental","pubTime":"2026-02-28 05:42","pubTimestamp":1772228526,"startTime":"0","endTime":"0","summary":"Arcturus Therapeutics Holdings Inc  expected to post a loss of71cents a share - Earnings Preview Arcturus Therapeutics Holdings Inc ARCT.OQ ARCT.O is expected to  show a fall in quarterly revenue when","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nL8N3ZN2SR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614832984","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2614832984","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614832984?lang=en_us&edition=fundamental","pubTime":"2026-02-27 19:00","pubTimestamp":1772190000,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Arbor Realty Tr                                  4Q       .13   8:30 AM. ·Delek US Hldgs                                    4Q      (.19)  7:00 AM. ·NW Natural Hldg                                  4Q      1.36   6:00 AM","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASAN","CRCT","CRD.B","CXDO","GSAT","CGEN","ANIP","BGS","CLMT","CRI","AMRX","CRC","STNE","CORZ","CRD.A","ALG","BBY","BCYC","AMWD","CMPX","ATRA","BRCB","ASTH","BRK.B","BRK.A","AZO","BOX","ANTA","ACEL","BLTE","ALXO","ACHR","AMR","ARCT","CERS","ABR","BEEP","AMRC","CVEO","AAON","NPCE","LIF","ADT","AMLX","ACRS","BTSG"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2612349517","title":"Press Release: Arcturus Therapeutics to Report Fourth Quarter and Fiscal Year 2025 Financial Results and Provide Corporate Update on March 3, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2612349517","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612349517?lang=en_us&edition=fundamental","pubTime":"2026-02-18 06:16","pubTimestamp":1771366560,"startTime":"0","endTime":"0","summary":"Arcturus Therapeutics Holdings Inc. , a commercial messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics and infectious disease vaccines, today announced that it will release its financial results for the quarter and year ended December 31, 2025 after the market close on Tuesday, March 3 and will also host a conference call and webcast at 4:30 p.m. Eastern Time on March 3, 2026.Arcturus Therapeutics Fourth Quarter and Fiscal Year 2025 Earnings Conference Call","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LENZ","BK4588","BK4139","RNA","BK4505","BK4585","BK4539","BK4232","CF","R","BK4022","ARCT","BK4093","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612246701","title":"Arcturus Therapeutics Holdings Inc. published an update to their financial calendar","url":"https://stock-news.laohu8.com/highlight/detail?id=2612246701","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612246701?lang=en_us&edition=fundamental","pubTime":"2026-02-18 05:01","pubTimestamp":1771362080,"startTime":"0","endTime":"0","summary":"Arcturus Therapeutics Holdings Inc. will release its fourth quarter and fiscal year 2025 financial results after the market close on Tuesday, March 3, 2026. The company will also host an earnings conference call and webcast at 4:30 p.m. Eastern Time on the same day. Results will be released on the Arcturus website. The webcast can be accessed via the following link: Webcast.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nNDL7Vy35B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARCT"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.arcturusrx.com","stockEarnings":[{"period":"1week","weight":0.1342},{"period":"1month","weight":0.0152},{"period":"3month","weight":0.2848},{"period":"6month","weight":-0.6441},{"period":"1year","weight":-0.2127},{"period":"ytd","weight":0.31}],"compareEarnings":[{"period":"1week","weight":0.0166},{"period":"1month","weight":-0.036},{"period":"3month","weight":-0.04},{"period":"6month","weight":-0.02},{"period":"1year","weight":0.1617},{"period":"ytd","weight":-0.0383}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Arcturus Therapeutics Holdings Inc., a late-stage clinical messenger RNA medicines and vaccine company, focuses on the development of infectious disease vaccines and other products within liver and respiratory rare diseases. Its technology platforms include LUNAR lipid-mediated delivery and STARR mRNA. The company is developing ARCT-810 (LUNAR-OTC), a mRNA-based therapeutic candidate, which is in Phase 2 clinical trial for treating ornithine transcarbamylase deficiency; and ARCT-154 (LUNAR-COV19), a mRNA vaccine candidate that is in Phase 3 arm of a Phase 1/2/3 study in Vietnam for the treatment of COVID-19, as well as ARCT-032 (LUNAR-CF), a mRNA therapeutic candidate for cystic fibrosis. The company was founded in 2013 and is headquartered in San Diego, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.538462,"avgChangeRate":0.084619},{"month":2,"riseRate":0.538462,"avgChangeRate":0.016903},{"month":3,"riseRate":0.230769,"avgChangeRate":-0.051078},{"month":4,"riseRate":0.615385,"avgChangeRate":0.10538},{"month":5,"riseRate":0.583333,"avgChangeRate":0.094979},{"month":6,"riseRate":0.615385,"avgChangeRate":0.024246},{"month":7,"riseRate":0.538462,"avgChangeRate":0.096382},{"month":8,"riseRate":0.538462,"avgChangeRate":0.072518},{"month":9,"riseRate":0.384615,"avgChangeRate":-0.052457},{"month":10,"riseRate":0.384615,"avgChangeRate":-0.077832},{"month":11,"riseRate":0.615385,"avgChangeRate":0.033635},{"month":12,"riseRate":0.307692,"avgChangeRate":-0.064746}],"exchange":"NASDAQ","name":"Arcturus Therapeutics Ltd.","nameEN":"Arcturus Therapeutics Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Arcturus Therapeutics Ltd.(ARCT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Arcturus Therapeutics Ltd.(ARCT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Arcturus Therapeutics Ltd.,ARCT,Arcturus Therapeutics Ltd.股票,Arcturus Therapeutics Ltd.股票老虎,Arcturus Therapeutics Ltd.股票老虎国际,Arcturus Therapeutics Ltd.行情,Arcturus Therapeutics Ltd.股票行情,Arcturus Therapeutics Ltd.股价,Arcturus Therapeutics Ltd.股市,Arcturus Therapeutics Ltd.股票价格,Arcturus Therapeutics Ltd.股票交易,Arcturus Therapeutics Ltd.股票购买,Arcturus Therapeutics Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Arcturus Therapeutics Ltd.(ARCT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Arcturus Therapeutics Ltd.(ARCT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}